|
|
Volumn 18, Issue 4, 2001, Pages 239-242
|
|
Arsenic trioxide: A new immunomodulatory agent in the management of multiple myeloma
|
|
Author keywords
Apoptosis; Arsenic trioxide; Immunomodulation; Multiple myeloma
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARSENIC TRIOXIDE;
ASCORBIC ACID;
CD38 ANTIGEN;
IMMUNOMODULATING AGENT;
INTERCELLULAR ADHESION MOLECULE 1;
ANTIGEN EXPRESSION;
BONE ATROPHY;
CELL CLONE;
CELL INTERACTION;
CELL PROLIFERATION;
DRUG ELIMINATION;
DRUG MECHANISM;
DRUG URINE LEVEL;
IMMUNE DEFICIENCY;
IMMUNOMODULATION;
KIDNEY DISEASE;
LYMPHOKINE ACTIVATED KILLER CELL;
LYMPHOPROLIFERATIVE DISEASE;
MULTIPLE MYELOMA;
PLASMA CELL;
PRIORITY JOURNAL;
REVIEW;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
ARSENICALS;
BIOLOGICAL RESPONSE MODIFIERS;
CLINICAL TRIALS;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
MULTIPLE MYELOMA;
OXIDES;
|
|
EID: 0035671654
PISSN: 13570560
EISSN: None
Source Type: Journal
DOI: 10.1385/MO:18:4:239 Document Type: Review |
|
Times cited : (30)
|
|
References (9)
|
